Patient info Open main menu

Sodium Feredetate 190mg/5ml Oral Solution – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
190 mg / 5 ml
Contains active substance:

Patient leaflet - Sodium Feredetate 190 mg / 5 ml oral solution

1. WHAT SODIUM FEREDETATE IS AND WHAT IT IS USED FOR

The name of your medicine is Sodium Feredetate 190 mg/5 ml Oral Solution (called Sodium Feredetate throughout this leaflet).

Sodium Feredetate is used to treat anaemia caused by too little iron in the body (iron deficiency anaemia). The form of iron used in this product means that it is less likely to cause stomach upsets than other iron-containing medicines, and will not discolour teeth.

It is to be taken by:

  • pregnant women when other forms of oral iron may not be well tolerated
  • children and adults who have become anaemic as a result of having rheumatoid arthritis.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SODIUM

FEREDETATE

Do not take Sodium Feredetate

  • if you are allergic to sodium feredetate (also known as sodium iron

    edetate) or any of the ingredients of this medicine (listed in section 6).

  • if you have a history of sensitivity to iron-containing preparations.
  • if you have a disorder in which there is excessive absorption and storage

    of (iron haemochromatosis or haemosiderosis).

  • if you have repeated blood transfusions or have had them in the past.
  • if you are currently having iron injections.

Warnings and precautions

Talk to your doctor or pharmacist before using Sodium Feredetate:

  • if you have haemolytic anaemia
  • if you have an iron storage or absorption disease
  • if you have gastrointestinal disease
  • if a child has been taking Sodium feredetate for a long time or at high

    doses as this can lead to toxic accumulation in the body

  • if you are having tests on your stools as iron preparations colour the

    faeces black and can interfere with test results

Other medicines and Sodium Feredetate

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

This includes any medicines you buy without a prescription, including iron- containing medicines or tonics. This is because Sodium Feredetate can affect the way in which some other medicines work. Also some medicines

can affect the way Sodium Feredetate works.

Tell your doctor if you are taking any of the following:

  • dimercaprol (for metal poisoning)
  • iron-containing medicines or tonics
  • chloramphenicol, fluoroquinolones or tetracyclines (to treat infections)
  • penicillamine (for rheumatoid arthritis)
  • methyldopa (for high blood pressure)
  • mycophenolate (to prevent organ transplant rejection)
  • levodopa, carbidopa or entacapone (for Parkinson’s disease)
  • bisphosphonates (for osteoporosis)
  • thyroxine (for thyroid problems)
  • trientine (for Wilson’s Disease)
  • cholestyramine (for high cholesterol)
  • proton-pump-inhibitors e.g. omeprazole (for stomach ulcers)
  • bicarbonates, carbonates, calcium, magnesium, zinc and other mineral supplements (indigestion and antacid remedies)
  • tea, coffee, eggs, milk, ascorbic acid (vitamin c) and citric acid, these may interfere with Sodium feredetate.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine

Driving and using machines

Sodium Feredetate is not expected to have an effect on your ability to drive or operate machinery.

Sodium Feredetate contains:

  • Methyl parahydroxybenzoate (E218)., propyl parahydroxybenzoate

    (E216). These ingredients may cause allergic reactions (possibly delayed).

  • Ponceau 4R (E124). This ingredient may cause allergic reactions.
  • Sorbitol. This medicine contains 1050 mg per 5 ml of solution which is

    equivalent to 210 mg per ml of solution. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars, or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine. Sorbitol may cause gastrointestinal discomfort and mild laxative effect.

  • Ethanol (alcohol). This medicine contains 11 mg of alcohol (ethanol) in

    each 5 ml of solution which is equivalent to 2.2 mg per ml of solution. The amount in 5ml of this medicine is equivalent to less than 1 ml beer or 1 ml wine.

Information on Sodium content

  • Sodium. This medicine contains less than 1 mmol sodium (23 mg) per

    dose, that is to say essentially ‘sodium-free’.

    o To be given by a healthcare professional only.

  • Babies (6 to 24 months):

    o 1 x 2.5 ml spoonful daily.

  • Children (2 to 5 years):

    o 1 x 5 ml spoonful daily.

  • Children (6 to 11 years):

    o 1 - 2 x 5 ml spoonful daily.

  • Adolescents

    o 2 x 5 ml spoonful daily.

*Elemental iron is iron your body can absorb.

If you take more Sodium Feredetate than you should

If you accidentally take too much Sodium Feredetate or give too much to a child, tell your doctor or contact your hospital immediately. Take this leaflet, the container and any remaining oral solution with you.

An overdose may cause:

  • you to feel sick (nausea)
  • you to be sick (vomiting, which may contain blood)
  • stomach pains
  • diarrhoea
  • blood in your stools

PACKAGE LEAFLET: INFORMATION FOR THE USER SODIUM FEREDETATE

190 MG/5 ML ORAL SOLUTION (equivalent to 27.5 mg of elemental iron/5 ml)

190mg/

5ml

Each 5ml dose contains Sodium Feredetate 190mg

(equivalent to 27.5mg of elemental iron/5ml)

Also contains sorbitol (E420), methyl hydroxybenzoate

(E218), propyl hydroxybenzoate (E216), ponceau 4R

lake (E124) and ethanol.

For oral administration. Read the package leaflet before

use.

Keep out of the sight and reach of children.

Important warning: Contains iron. Keep out of the sight and reach of children, as overdose may be fatal.

Store in the original package in order to protect from

light. Use with in three months of opening.

Use as directed by your physician.

Marketing Authorisation Holder:

Mercury Pharmaceuticals Ltd, Dashwood House,

69 Old Broad Street, London, EC2M 1QS, United Kingdom

PL 12762/0537 POM

3. HOW TO TAKE SODIUM FEREDETATE

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Method of administration

The oral solution is to be taken by mouth.

The recommended dose is:

Treatment of anaemia

  • Adults (including elderly older than 65 years):

    o 1 or 2 x 5 ml spoonful 3 times a day.

  • Children:

    o 3 to 6 mg of elemental iron per 1 kg of body weight

    o The maximum daily dose is 200 mg of elemental iron* (36.3 ml of

    Sodium Feredetate), divided into 2 or 3 daily doses

    o To be given by a healthcare professional only.

Prevention of anaemia

  • Babies of low birth-weight who are solely breast-fed:

    o 5 mg of elemental iron* (0.9 ml of Sodium Feredetate given in a 1 ml syringe) daily.

    o Depending on the body weight, a higher dose (up to 2 mg per 1 kg of body weight) of elemental iron* daily may be required for exclusively breast-fed babies.

    Sodium Feredetate #190mg/5ml Oral Solution

Sodium Feredetate #190mg/5ml Oral Solution

Sodium Feredetate #190mg/5ml Oral Solution

E2246 AW-LL-0000005 (v0.2)

E2246 AW-LL-0000005 (v0.2)

and technical approval needs to be taken, from the CMO, before Implementation.

Dimension: 143 x 105 mm Commodity No.: E2246

Version No.: AW-LL-0000005

(v0.2)

Product Description: Sodium Ferede-tate 190mg/5ml Oral Solution - 500 ml

Component: LL

Product Code: 103802

Country: UK

Vendor Name: Dales

Revision Date: 10-Jan-2024 Revised by:

Marketing Authorisation Holder:

Mercury Pharmaceuticals Ltd, Dashwood House,

69 Old Broad Street, London, EC2M 1QS, United Kingdom

PL 12762/0537 POM

  • tiredness
  • cold and sweaty skin
  • fast heart beat
  • high blood sugar
  • high blood acidity (metabolic acidosis).

If you forget to take Sodium Feredetate

If you forget a dose, take it as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Sodium Feredetate can cause side effects, although not everybody gets them.

You may feel sick (nausea) or have mild diarrhoea in the early stages of treatment. These effects should quickly disappear if you stop taking Sodium Feredetate for a short time.

When treatment is restarted, a lower dose of your medicine should be taken. If you are not sure what your dose should be, talk to your doctor. If your doctor tells you to take Sodium Feredetate at doses higher than is stated in this leaflet, you may experience mild diarrhoea.

If you experience any of the following side effects, STOP taking Sodium Feredetate and see a doctor or go to a hospital IMMEDIATELY:

  • allergic reactions – symptoms may include itchy skin rash, swelling of the

    face, lips, tongue or throat, or difficulty breathing or swallowing.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard or or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE SODIUM FEREDETATE

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the bottle label after EXP. The expiry date refers to the last day of the month. Do not use Sodium Feredetate after the bottle has been opened for more than 3 months.

Store in the original package in order to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Sodium Feredetate contains

The active substance is sodium feredetate (also known as sodium iron edetate) 190 mg/5 ml.

The other ingredients are methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), citric acid monohydrate, saccharin sodium, glycerol, sorbitol (E420), ethanol, ponceau 4R (E124), black cherry flavouring and water.

What Sodium Feredetate looks like and contents of the pack

Sodium feredetate is a red coloured liquid. It is supplied in amber-coloured glass bottles with a child resistant cap containing 500ml of oral solution. Marketing Authorisation Holder

Mercury Pharmaceuticals Ltd,

Dashwood House, 69 Old Broad Street,

London, EC2M 1QS,

United Kingdom

Manufacturer

Dales Pharmaceuticals Limited, Snaygill Industrial Estate, Keighley Road, Skipton, North Yorkshire, BD23 2RW, United Kingdom

This leaflet was last revised in January 2024.

AW-LL-0000005 (v0.2)

E2246

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 12762/0537

Last revision stated in the text: January 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sodium Feredetate 190 mg / 5 ml oral solution

Active substance Sodium feredetate
Strength 190 mg / 5 ml
Pharmaceutical form Red coloured liquid.
Excipients Methyl parahydroxybenzoate (E218), Propyl parahydroxybenzoate (E216), Saccharin Sodium, Glycerol, Sorbitol liquid (E420), Ethanol, Black cherry flavour, Ponceau 4R (E124), Citric acid monohydrate, Water
Shelf life Unopened: 3 years.
Opened: 3 months from date of opening
Storage Store in the original package in order to protect from light.
Drug group (ATC) Iron preparations
  1. B Blood and blood forming organ drugs
    1. B03 Antianemic preparations
      1. B03A Iron antianemic preparations
Marketing authorisation PL 12762/0537 (first authorised 14 January 2025)
Marketing authorisation holder Mercury Pharmaceuticals Ltd

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.